| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.07e-05 | 206 | 5 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 7.25e-04 | 172 | 5 | 2 | GO:0008757 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 1.11e-03 | 213 | 5 | 2 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 1.23e-03 | 224 | 5 | 2 | GO:0016741 | |
| GeneOntologyMolecularFunction | histone binding | 1.71e-03 | 265 | 5 | 2 | GO:0042393 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.79e-03 | 1160 | 5 | 3 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.82e-03 | 1356 | 5 | 3 | GO:0060090 | |
| GeneOntologyBiologicalProcess | chromatin organization | 7.65e-04 | 896 | 5 | 3 | GO:0006325 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.05e-03 | 999 | 5 | 3 | GO:0071824 | |
| GeneOntologyBiologicalProcess | methylation | 1.25e-03 | 234 | 5 | 2 | GO:0032259 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 2.05e-03 | 1256 | 5 | 3 | GO:0051726 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 4.83e-03 | 464 | 5 | 2 | GO:0045786 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 3.12e-03 | 254 | 5 | 2 | M27131 | |
| Pubmed | 9.09e-07 | 11 | 5 | 2 | 37012455 | ||
| Pubmed | Rebalancing gene haploinsufficiency in vivo by targeting chromatin. | 6.24e-06 | 28 | 5 | 2 | 27256596 | |
| Pubmed | 1.56e-05 | 44 | 5 | 2 | 24183668 | ||
| Pubmed | 7.19e-05 | 94 | 5 | 2 | 16325481 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.74e-04 | 146 | 5 | 2 | 23892456 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 2.24e-04 | 125 | 5 | 2 | MM1065 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP | 3.39e-04 | 154 | 5 | 2 | M8927 | |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP | 5.43e-04 | 195 | 5 | 2 | M3319 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 5.65e-04 | 199 | 5 | 2 | M7131 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP | 5.65e-04 | 199 | 5 | 2 | M7329 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 5.71e-04 | 200 | 5 | 2 | M6477 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 8.68e-04 | 247 | 5 | 2 | MM1081 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 7.15e-03 | 721 | 5 | 2 | M10237 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | 2.15e-02 | 1276 | 5 | 2 | M39173 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 2.54e-02 | 1394 | 5 | 2 | M9585 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 2.89e-02 | 1492 | 5 | 2 | M40023 | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 145 | 5 | 2 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.89e-04 | 197 | 5 | 2 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| Drug | AC1NQAN2 | 3.15e-06 | 17 | 4 | 2 | CID005193003 | |
| Drug | AC1L9KN8 | 6.38e-06 | 24 | 4 | 2 | CID000447254 | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 4.33e-04 | 195 | 4 | 2 | 1837_DN |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WKFRQQMRQKSKQQA | 1751 | Q8NEZ4 | |
| SWTKNRMWRKNRSKN | 226 | P15088 | |
| RMWRKNRSKNQNSKC | 231 | P15088 | |
| NMNSKRKAETWKRNR | 261 | Q15208 | |
| KQWRNRQKNKRRCKN | 186 | O43159 | |
| QVKTWFQNQRMKSKR | 81 | Q8N7R0 | |
| FQNQRMKSKRWQKNN | 86 | Q8N7R0 |